Phillip A. Weeks, PharmD, BCPS

Evaluation of Bivalirudin Hyper- and Hypo-ACT Responses in the Setting of Percutaneous Coronary Intervention

04/25/2013

The role of ACT monitoring of bivalirudin in PCI is not defined based on current practice guidelines. We investigated whether hyper- and hypo-ACT responses to bivalirudin in PCI may be associated with excessive bleeding or thrombotic...

The role of ACT monitoring of...

04/25/2013

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Phillip A. Weeks, PharmD, BCPS

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products